Leppik 1983.
| Methods | Randomised, placebo‐controlled, parallel group design | |
| Participants | Adults (mean age 53 years), male 71%. Setting: University hospitals | |
| Interventions | Arm 1 = lorazepam 2 mg IV
Arm 2 = diazepam 5 mg IV One or two doses to achieve seizure control |
|
| Outcomes | Cessation of seizures after first dose
Recovery at discharge
Mortality in hospital
Requirement for ventilatory support
Complications
Adverse effects Patients followed up until discharge from hospital |
|
| Notes | Study conducted in USA, multi‐centric (three centres) | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Randomly numbered identical kits |
| Allocation concealment (selection bias) | Low risk | Randomly numbered identical kits |
| Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double blinded |
| Blinding of outcome assessment (detection bias) All outcomes | Low risk | Double blinded |